Showing results (1711-1720 of 2,199) with videos related to
Sort By:
Pageof 220
Multiple Sclerosis and Related Disorders|October 24, 2022
The symbol digit modalities test and the paced auditory serial addition test involve more than processing speedLindsay I Berrigan, Jo-Anne LeFevre, Laura M Rees, et al.Annals of Surgical Oncology|May 10, 2021
Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal TumorThomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.Surgery|June 6, 2021
Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role?Thomas L Sutton, Brett S Walker, Kevin G Billingsley, et al.The Journal of Pediatrics|April 1, 1988
Determinants of low serum concentrations of salicylates in patients with Kawasaki diseaseG Koren, F Schaffer, E Silverman, et al.Journal of Materials Science. Materials in Medicine|June 15, 2011
Composites for bone repair: phosphate glass fibre reinforced PLA with varying fibre architectureI Ahmed, I A Jones, A J Parsons, et al.British Journal of Cancer|April 14, 2012
The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular functionL C J Baker, J K R Boult, S Walker-Samuel, et al.Journal of Pediatric Gastroenterology and Nutrition|January 22, 2004
Recurrent abdominal pain: symptom subtypes based on the Rome II Criteria for pediatric functional gastrointestinal disordersLynn S Walker, Tricia A Lipani, John W Greene, et al.Oncogene|March 2, 2010
Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1S A Caldwell, S R Jackson, K S Shahriari, et al.Diabetes, Obesity & Metabolism|September 20, 2014
Randomized efficacy and safety trial of once-daily remogliflozin etabonate for the treatment of type 2 diabetesA P Sykes, G L Kemp, R Dobbins, et al.IJTLD Open|March 17, 2025
Costs and cost-effectiveness of integrated screening for non-communicable diseases in TB contactsY Hamada, R Mukora, R Pelusa, et al.Pageof 220